Jiashu Xie

839 total citations
48 papers, 658 citations indexed

About

Jiashu Xie is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Jiashu Xie has authored 48 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 19 papers in Molecular Biology and 14 papers in Virology. Recurrent topics in Jiashu Xie's work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (14 papers) and Hepatitis C virus research (8 papers). Jiashu Xie is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (14 papers) and Hepatitis C virus research (8 papers). Jiashu Xie collaborates with scholars based in United States, China and Japan. Jiashu Xie's co-authors include Zhengqiang Wang, Jayakanth Kankanala, Stefan G. Sarafianos, Daniel J. Wilson, Liqiang Chen, Swati S. More, Mary C. Casey, Karen A. Kirby, Lei Wang and Rajkumar Lalji Sahani and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Jiashu Xie

45 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiashu Xie United States 17 289 230 140 120 97 48 658
Dabo Pan China 16 382 1.3× 86 0.4× 20 0.1× 78 0.7× 87 0.9× 46 655
Judy S. Mathew United States 10 220 0.8× 206 0.9× 73 0.5× 123 1.0× 103 1.1× 13 466
Biehuoy Shieh United States 17 266 0.9× 55 0.2× 65 0.5× 86 0.7× 47 0.5× 33 655
Fisayo A. Olotu South Africa 18 439 1.5× 144 0.6× 31 0.2× 103 0.9× 160 1.6× 79 857
Dinesh Manvar United States 16 245 0.8× 92 0.4× 19 0.1× 75 0.6× 345 3.6× 31 722
Haiying Bao China 14 359 1.2× 410 1.8× 43 0.3× 347 2.9× 65 0.7× 39 902
Ge Fu China 10 371 1.3× 66 0.3× 14 0.1× 162 1.4× 58 0.6× 11 660
Pritika Ramharack South Africa 13 224 0.8× 149 0.6× 18 0.1× 63 0.5× 62 0.6× 39 537
Paula M. Brito Portugal 11 257 0.9× 57 0.2× 48 0.3× 53 0.4× 35 0.4× 15 571
Carmine Talarico Italy 16 316 1.1× 163 0.7× 23 0.2× 23 0.2× 72 0.7× 37 544

Countries citing papers authored by Jiashu Xie

Since Specialization
Citations

This map shows the geographic impact of Jiashu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiashu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiashu Xie more than expected).

Fields of papers citing papers by Jiashu Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiashu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiashu Xie. The network helps show where Jiashu Xie may publish in the future.

Co-authorship network of co-authors of Jiashu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Jiashu Xie. A scholar is included among the top collaborators of Jiashu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiashu Xie. Jiashu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhengqiang, et al.. (2025). Methylation Enables Sensitive LC-MS/MS Quantification of Ciclopirox in a Mouse Pharmacokinetics Study. Molecules. 30(17). 3599–3599.
2.
Belhadj, Zakia, et al.. (2024). Characterization of a deazaflavin analog as a potent inhibitor of multidrug resistance-associated protein 1. Biomedicine & Pharmacotherapy. 178. 117167–117167. 3 indexed citations
3.
Singh, Rohit, Rongrong Jiang, J.M. Williams, et al.. (2024). Modulation of endogenous opioid signaling by inhibitors of puromycin-sensitive aminopeptidase. European Journal of Medicinal Chemistry. 275. 116604–116604. 1 indexed citations
4.
Belhadj, Zakia, et al.. (2023). Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation. European Journal of Pharmaceutical Sciences. 193. 106686–106686. 1 indexed citations
5.
Soto-Acosta, Rubén, et al.. (2022). Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase. ACS Medicinal Chemistry Letters. 13(9). 1477–1484. 23 indexed citations
6.
7.
Xie, Wei, Haizhou Zhu, Jiashu Xie, et al.. (2021). γ-Glutamyl-Transpeptidase-Resistant Glutathione Analog Attenuates Progression of Alzheimer’s Disease-like Pathology and Neurodegeneration in a Mouse Model. Antioxidants. 10(11). 1796–1796. 11 indexed citations
8.
Wang, Lei, Rajkumar Lalji Sahani, Jiashu Xie, et al.. (2021). Metal binding 6-arylthio-3-hydroxypyrimidine-2,4-diones inhibited human cytomegalovirus by targeting the pUL89 endonuclease of the terminase complex. European Journal of Medicinal Chemistry. 222. 113640–113640. 7 indexed citations
9.
Xie, Jiashu, Rongrong Jiang, Wei Xie, Bin Cao, & Swati S. More. (2021). LC-MS/MS determination of guanabenz E/Z isomers and its application to in vitro and in vivo DMPK profiling studies. Journal of Pharmaceutical and Biomedical Analysis. 205. 114331–114331. 6 indexed citations
10.
Wang, Lei, Mary C. Casey, Sanjeev Kumar V. Vernekar, et al.. (2020). Novel HIV-1 capsid-targeting small molecules of the PF74 binding site. European Journal of Medicinal Chemistry. 204. 112626–112626. 19 indexed citations
11.
Wang, Lei, Mary C. Casey, Sanjeev Kumar V. Vernekar, et al.. (2020). Chemical profiling of HIV-1 capsid-targeting antiviral PF74. European Journal of Medicinal Chemistry. 200. 112427–112427. 21 indexed citations
12.
Kiselev, Evgeny, et al.. (2019). Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors. DNA repair. 85. 102747–102747. 15 indexed citations
13.
Ding, Rui, Ting Zhang, Daniel J. Wilson, et al.. (2019). Discovery of Irreversible p97 Inhibitors. Journal of Medicinal Chemistry. 62(5). 2814–2829. 19 indexed citations
14.
Tang, Jing, Andrew D. Huber, Jennifer J. Wolf, et al.. (2018). 5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors. European Journal of Medicinal Chemistry. 164. 179–192. 17 indexed citations
15.
Wang, Lei, Jing Tang, Andrew D. Huber, et al.. (2018). 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity. European Journal of Medicinal Chemistry. 156. 652–665. 27 indexed citations
16.
Ai, Teng, Rose Willett, J.M. Williams, et al.. (2016). N-(1-Benzyl-3,5-dimethyl-1H-pyrazol-4-yl)benzamides: Antiproliferative Activity and Effects on mTORC1 and Autophagy. ACS Medicinal Chemistry Letters. 8(1). 90–95. 12 indexed citations
17.
Xie, Jiashu, et al.. (2016). Glutathione disulfide liposomes – A research tool for the study of glutathione disulfide associated functions and dysfunctions. Biochemistry and Biophysics Reports. 7. 225–229. 11 indexed citations
18.
Zhou, Wenbo, Yan Wang, Jiashu Xie, & Robert J. Geraghty. (2016). A fluorescence-based high-throughput assay to identify inhibitors of tyrosylprotein sulfotransferase activity. Biochemical and Biophysical Research Communications. 482(4). 1207–1212. 12 indexed citations
19.
Ai, Teng, Li Qiu, Jiashu Xie, Robert J. Geraghty, & Liqiang Chen. (2015). Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid. Bioorganic & Medicinal Chemistry. 24(4). 686–692. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026